Series A - Palladio Biosciences

Series A - Palladio Biosciences

Investment Firm

Overview

Palladio Biosciences develops transformative medicines for orphan diseases of the kidney.

Announced Date

May 23, 2017

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Medicxi

Medicxi

Medicxi is a early_stage_venture and seed firm.

Participant Investors

1

Investor Name
Participant InvestorMedicxi

Round Details and Background

Palladio Biosciences raised an undisclosed amount on 2017-05-23 in Series A

Palladio Biosciences develops transformative medicines for orphan diseases of the kidney.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 23, 2017
Series A - Palladio Biosciences
1-undefined
Sep 25, 2020
Series B - Palladio Biosciences
4-20.0M

Recent Activity

There is no recent news or activity for this profile.